Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2014 Aug;7(8):824–838. doi: 10.1016/j.jcmg.2014.06.007

Figure 4. Clinical & Developmental Imaging of Cardiovascular Injury after cancer treatment.

Figure 4

Opportunities for utilizing existing (black boxed) and developmental (red boxed) noninvasive imaging technologies for identifying processes associated with myocellular, myofibroblast, myocardial conduction and vascular injuries associated with the administration of cancer therapies that may adversely impact the cardiovascular system. As shown, existing technologies identify mainly clinically evident manifestations of CV injury while developmental technologies may facilitate assessment of biomolecular pathways that precede end organ damage.